$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

$thmo Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000143774924012088 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$2.406M	$9.445M
YoY Change		-10.09%	-9.9%
Cost Of Revenue		$2.444M	$7.514M
YoY Change		7.1%	-3.33%
Gross Profit		-$38.00K	$1.931M
YoY Change		-109.64%	-28.75%
Gross Profit Margin		-1.58%	20.44%
Selling, General & Admin		$1.875M	$7.221M
YoY Change		18.75%	-0.32%
% of Gross Profit			373.95%
Research & Development		$329.0K	$1.284M
YoY Change		-3.8%	-22.6%
% of Gross Profit			66.49%
Depreciation & Amortization		$327.0K	$1.147M
YoY Change		25.77%	23.87%
% of Gross Profit			59.4%
Operating Expenses		$2.204M	$8.505M
YoY Change		14.73%	-4.47%
Operating Profit		-$2.242M	-$6.574M
YoY Change		46.82%	6.15%
Interest Expense		-$3.343M	-$10.03M
YoY Change		63.55%	-278.63%
% of Operating Profit
Other Income/Expense, Net		$22.00K	$49.00K
YoY Change		-1200.0%	-1733.33%
Pretax Income		-$7.599M	-$18.92M
YoY Change		112.68%	60.99%
Income Tax
% Of Pretax Income
Net Earnings		-$7.014M	-$17.98M
YoY Change		104.31%	52.18%
Net Earnings / Revenue		-291.52%	-190.31%
Basic Earnings Per Share			-$7.59
Diluted Earnings Per Share		-$2.18	-$7.59
COMMON SHARES
Basic Shares Outstanding	7.953M	3.137M	2.368M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.000M	$2.000M
YoY Change	-52.12%	-52.12%
Cash & Equivalents	$2.000M	$2.000M
Short-Term Investments
Other Short-Term Assets	$825.0K	$825.0K
YoY Change	-45.29%	-45.29%
Inventory	$1.406M	$1.406M
Prepaid Expenses
Receivables	$949.0K	$949.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.180M	$5.180M
YoY Change	-52.41%	-52.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.796M	$5.796M
YoY Change	362.2%	11.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$256.0K	$256.0K
YoY Change	0.0%	-79.67%
Total Long-Term Assets	$6.052M	$6.052M
YoY Change	-28.82%	-28.82%
TOTAL ASSETS
Total Short-Term Assets	$5.180M	$5.180M
Total Long-Term Assets	$6.052M	$6.052M
Total Assets	$11.23M	$11.23M
YoY Change	-42.06%	-42.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$948.0K	$948.0K
YoY Change	15.61%	15.61%
Accrued Expenses	$1.736M	$1.736M
YoY Change	-25.3%	-25.3%
Deferred Revenue	$670.0K
YoY Change	-14.32%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.656M	$7.656M
YoY Change	13.61%	13.61%
Total Short-Term Liabilities	$11.76M	$11.76M
YoY Change	2.2%	2.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.054M	$3.054M
YoY Change	17864.71%	-32.94%
Total Long-Term Liabilities	$3.054M	$3.054M
YoY Change	17864.71%	-32.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.76M	$11.76M
Total Long-Term Liabilities	$3.054M	$3.054M
Total Liabilities	$12.90M	$12.90M
YoY Change	-19.7%	-14.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$284.2M
YoY Change	6.75%
Common Stock	$4.000K
YoY Change	300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.667M	-$1.667M
YoY Change
Total Liabilities & Shareholders Equity	$11.23M	$11.23M
YoY Change	-42.06%	-42.06%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$7.014M	-$17.98M
YoY Change	104.31%	52.18%
Depreciation, Depletion And Amortization	$327.0K	$1.147M
YoY Change	25.77%	23.87%
Cash From Operating Activities	-$2.041M	-$3.721M
YoY Change	72.67%	-48.91%
INVESTING ACTIVITIES
Capital Expenditures	$193.0K	$1.733M
YoY Change	109.78%	333.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$193.0K	-$1.733M
YoY Change	109.78%	333.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.278M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	218.0K	3.278M
YoY Change	-85.93%	-28.52%
NET CHANGE
Cash From Operating Activities	-2.041M	-3.721M
Cash From Investing Activities	-193.0K	-1.733M
Cash From Financing Activities	218.0K	3.278M
Net Change In Cash	-2.016M	-2.176M
YoY Change	-833.09%	-29.87%
FREE CASH FLOW
Cash From Operating Activities	-$2.041M	-$3.721M
Capital Expenditures	$193.0K	$1.733M
Free Cash Flow	-$2.234M	-$5.454M
YoY Change	75.35%	-29.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3617886
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7514000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-18919000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3584000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1507000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	138000	usd
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	282383000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284168000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1667000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1917000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3584000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11232000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9445000	usd
CY2023	us-gaap	Gross Profit GrossProfit	1931000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1284000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1659000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	8903000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11812000	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000811212
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	45	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2827985	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7952780
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4177000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	149000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	949000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1865000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1406000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3334000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	825000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1508000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5180000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10884000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1003000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2586000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1254000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	781000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1286000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	256000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	256000	usd
CY2023Q4	us-gaap	Assets Assets	11232000	usd
CY2022Q4	us-gaap	Assets Assets	19386000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	948000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	820000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	376000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	399000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	670000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	782000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7278000	usd
CY2023Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	634000	usd
CY2022Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	1492000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	378000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	962000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1478000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1277000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11762000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11509000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	127000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	911000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14816000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16063000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3617886
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1037138
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1037138
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	270377000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-266193000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	111000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4296000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-973000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3323000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19386000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10483000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7773000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2710000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7221000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7244000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2036000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10541000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8610000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6193000	usd
CY2023	us-gaap	Interest Expense InterestExpense	10032000	usd
CY2022	us-gaap	Interest Expense InterestExpense	5616000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-326000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	49000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
CY2023	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-10309000	usd
CY2022	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-5619000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-18919000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11812000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-944000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-542000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17975000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11270000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-18919000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	80000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18916000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11732000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-944000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-542000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17972000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11190000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.59
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.45
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2368112
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	550993
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3323000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2640000	usd
CY2023	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	421000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3397000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	267000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1546000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	80000	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-11812000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3323000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-18919000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11812000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1147000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	926000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	39000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	267000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8305000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3487000	usd
CY2023	thmo	Inventory Change In Reserve InventoryChangeInReserve	1357000	usd
CY2022	thmo	Inventory Change In Reserve InventoryChangeInReserve	667000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-326000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2036000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-11000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-915000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1134000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1574000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2073000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-682000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	139000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	130000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-386000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	120000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-738000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-23000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	51000	usd
CY2023	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	-92000	usd
CY2022	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	63000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	181000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	330000	usd
CY2023	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-1499000	usd
CY2022	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-951000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3721000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7283000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1733000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	400000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1733000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-400000	usd
CY2023	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	2857000	usd
CY2022	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	4583000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	421000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3278000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4586000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-6000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2177000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3103000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4177000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7280000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4177000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	140000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	180000	usd
CY2023	thmo	Interest Paid Net Related Party InterestPaidNetRelatedParty	1492000	usd
CY2022	thmo	Interest Paid Net Related Party InterestPaidNetRelatedParty	2628000	usd
CY2023	thmo	Adjustments To Additional Paid In Capital Debt Discount AdjustmentsToAdditionalPaidInCapitalDebtDiscount	99000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2023Q4	thmo	Working Capital WorkingCapital	6582000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2021Q4	us-gaap	Goodwill Goodwill	781000	usd
CY2022	thmo	Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss	-32000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1286000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	781000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but not limited to, the allowance for credit losses, carrying amounts of inventories, depreciation and amortization, warranty obligations, assumptions made in valuing financial instruments issued in various compensation and financing arrangements, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company’s consolidated financial statements.</p>
CY2023	thmo	Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss	-31000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1255000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1003000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Credit Risk</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit-worthiness of the Company’s customers. The Company believes that adequate provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has not experienced significant credit related losses.</p>
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	781000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Reclassifications</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not have an impact on net loss as previously reported. As a result of the reverse stock split effected by the Company on December 22, 2022, common stock and additional paid in capital amounts from prior periods were adjusted as to reflect if the reverse split had occurred in the prior periods. For revenue by product line, manual disposables where consolidated into the other line item as the Company discontinued sales of that product in 2023.</p>
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10159000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8429000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7575000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7175000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2586000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1254000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	131000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	391000	usd
CY2023	us-gaap	Depreciation Depreciation	400000	usd
CY2022	us-gaap	Depreciation Depreciation	387000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1255000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	781000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1318000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.22	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.22	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	139000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	131000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	329000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	319000	usd
CY2020Q3	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	1000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	125000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2640000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	360000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.3
CY2022Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2055000	usd
CY2022Q4	thmo	Proceeds From Issuance Or Sale Of Equity Net ProceedsFromIssuanceOrSaleOfEquityNet	1549000	usd
CY2022Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	506000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	14518
CY2021Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	313.71
CY2021	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P1Y5M8D
CY2022	thmo	Class Of Warrant Or Right Granted During Period ClassOfWarrantOrRightGrantedDuringPeriod	326171
CY2022	thmo	Class Of Warrant Or Right Granted During Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantedDuringPeriodWeightedAverageExercisePrice	6.3
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	340689
CY2022Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	19.4
CY2022	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P0Y3M21D
CY2022Q4	thmo	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	14518
CY2022Q4	thmo	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	313.71
CY2022	thmo	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm	P0Y5M8D
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	340689
CY2022Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	19.4
CY2023	thmo	Class Of Warrant Or Right Granted During Period ClassOfWarrantOrRightGrantedDuringPeriod	1071429
CY2023	thmo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	158731
CY2023	thmo	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod	14518
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1238869
CY2023Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.14
CY2023	thmo	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm	P4Y6M25D
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	267000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	267000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11881553
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1872843
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9445000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10483000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9445000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10483000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	782000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	719000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	670000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	782000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	127000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	911000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	527000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	13000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	83000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2268000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18982000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-63000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11752000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-60000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3973000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2481000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3779000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-284000	usd
CY2023	thmo	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount	1469000	usd
CY2022	thmo	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount	1356000	usd
CY2023	thmo	Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount	2210000	usd
CY2022	thmo	Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount	1179000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3508000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	200000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	11000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	23000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	19000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29233000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26465000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	2676000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	2738000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	620000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	421000	usd
CY2023Q4	thmo	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	1015000	usd
CY2022Q4	thmo	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	908000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	75000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	251000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1003000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	517000	usd
CY2023Q4	thmo	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	488000	usd
CY2022Q4	thmo	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	317000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	267000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	159000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35377000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31776000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	252000	usd
CY2023Q4	thmo	Deferred Tax Liabilities Lease Asset DeferredTaxLiabilitiesLeaseAsset	898000	usd
CY2022Q4	thmo	Deferred Tax Liabilities Lease Asset DeferredTaxLiabilitiesLeaseAsset	824000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	898000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1076000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34479000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30700000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3779000000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-284000	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	119000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	132000	usd

Files In Submission

Name	View Source	Status
0001437749-24-012088-index-headers.html	Edgar Link	pending
0001437749-24-012088-index.html	Edgar Link	pending
0001437749-24-012088.txt	Edgar Link	pending
0001437749-24-012088-xbrl.zip	Edgar Link	pending
ex_650703.htm	Edgar Link	pending
ex_650704.htm	Edgar Link	pending
ex_650705.htm	Edgar Link	pending
ex_650706.htm	Edgar Link	pending
ex_652553.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thmo-20231231.xsd	Edgar Link	pending
thmo20231231_10k.htm	Edgar Link	pending
thmo20231231_10kimg001.jpg	Edgar Link	pending
thmo-20231231_def.xml	Edgar Link	unprocessable
thmo-20231231_pre.xml	Edgar Link	unprocessable
thmo-20231231_lab.xml	Edgar Link	unprocessable
thmo20231231_10k_htm.xml	Edgar Link	completed
thmo-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

2024 Q2 Form 10-K Financial Statement

#000143774924012088 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO ThermoGenesis Holdings, Inc. Stock $thmo

2024 Q2 Form 10-K Financial Statement

#000143774924012088 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo